Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
ENVISION HLTHCR.LTD. (US), a company active in the Health Care Providers industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 2 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date October 2, 2018, the closing price wa...
Moody's Investors Service (Moody's) placed the ratings for Envision Healthcare Corporation ("Envision") on review for downgrade, including the B1 Corporate Family Rating, B1-PD Probability of Default Rating, and all debt instrument ratings. The outlook, previously stable, is also on re...
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Envision Healthcare Corporation (“Envision”) (NYSE: EVHC) today reported solid financial results for the three months ended March 31, 2018, driven by Physician Services’ revenue growth and initial contributions from the Company’s 2018 operational improvement initiatives. Highlights for the first quarter of 2018 include: Net revenue from continuing operations of $2.08 billion; Net earnings from continuing operations attributable to common stockholders of $3...
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Envision Healthcare Corporation (“Envision”) (NYSE: EVHC) today announced the completion of the previously announced divestiture of its medical transportation business, American Medical Response, to an entity affiliated with KKR. The divestiture is a major step in rationalizing Envision’s physician services and ambulatory surgery portfolio. Envision anticipates using the net proceeds of approximately $2.1 billion from the sale to reduce debt outstanding under its existing Term Loan B credit facility...
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Envision Healthcare Corporation (NYSE: EVHC) today announced that its management will present at the Raymond James 39th Annual Institutional Investors Conference on Wednesday, March 7, 2018, in Orlando, Florida. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the company’s web site starting at 8:40 a.m. Eastern Time. The live audio webcast and replay of the presentation will be available on the investor relations section of...
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Envision Healthcare Corporation (“Envision”) (NYSE: EVHC) today reported financial results for the three and 12 months ended December 31, 2017, that exceeded its most recent Adjusted EBITDA and Adjusted earnings per share guidance. Highlights for the fourth quarter of 2017 include: Net revenue from continuing operations of $2.00 billion; Net earnings from continuing operations attributable to common stockholders of $137.8 million or $1.13 per diluted share...
NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Envision Healthcare Corporation (NYSE: EVHC) today provided preliminary fourth quarter results, announced the date for the release of its financial results for the fourth quarter and full year 2017 and extended the director nomination deadline. Preliminary Fourth Quarter Results For the three months ended December 31, 2017, Envision expects to report net revenue from continuing operations of approximately $2.0 billion and Adjusted EBITDA from continuing o...
NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) today provided a business and governance update regarding a number of initiatives to execute on its long-term strategy and increase shareholder value. Governance Update Envision has announced that its Board of Directors (“Board”) has appointed James D. “Denny” Shelton as Lead Independent Director, effective immediately. Mr. Shelton has served as a Director since May 2015 and...
NEW YORK--(BUSINESS WIRE)-- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, is investigating whether certain directors and officers of Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) breached their fiduciary duties to the Company and its shareholders. If you are an Envision shareholder, you are encouraged to contact Scott+Scott for additional information. Operating under the brands of EmCare and others, Envision provides an array...
NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Envision Healthcare Corporation (“Envision”) (NYSE: EVHC) today reported financial results for the three and nine months ended September 30, 2017. Envision’s operations were disrupted by Hurricanes Harvey and Irma during the third quarter of 2017, and the Company estimates that its results from continuing operations include a negative impact of $22.0 million of revenue and $22.0 million of Adjusted EBITDA. Highlights for the third quarter of 2017 include: ...
NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE:EVHC) of the October 3, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Envision stock or options between March 2, 2015 and July 21, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/EVHC. There is no cost or obligati...
NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) today announced the authorization of a program to repurchase up to $250 million of its common stock. The decision to return capital to shareholders is a reflection of the Company’s successful efforts to rationalize its service offerings around a physician-centric strategy and confidence in its ability to differentiate Envision through its stated plan to drive operational excellence and long-term growth. ...
NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) today announced organizational changes, including a realignment of the senior leadership structure under Christopher A. Holden, Envision’s President and Chief Executive Officer, to reflect the Company’s focus on its physician-centric strategic plan. As part of its ongoing efforts to enhance its scale, physician-centric strategy and operational excellence, Envision has created the new role o...
NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE:EVHC) of the October 3, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Envision stock or options between March 2, 2015 and July 21, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/EVHC. There is no cost or obligati...
RADNOR, Pa.--(BUSINESS WIRE)-- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Envision Healthcare Corporation (NYSE: EVHC) (“Envision” or the “Company”) shareholders that a class action lawsuit has been filed on behalf of purchasers of the Company’s securities between March 2, 2015 and July 21, 2017, inclusive (the “Class Period”). REMINDER: Envision shareholders who purchased securities during the Class Period may, no later than October 3, 2017, seek to be appointed as a lead plaintiff representative of the class...
NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Envision Healthcare Corporation (NYSE: EVHC) today announced that its management will present at two healthcare research conferences in September. On Wednesday, September 6, 2017, the Company will present at the Baird 2017 Global Healthcare Conference in New York. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the company’s web site starting at 3:10 p.m. Eastern Time. On Thursday,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.